AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 194 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,465,752,000 | -51.4% | 145,846 | -40.1% | 0.01% | -44.4% |
| Q1 2022 | $3,013,701,000 | -43.7% | 243,433 | +4.1% | 0.02% | -41.9% |
| Q4 2021 | $5,349,156,000 | -44.9% | 233,894 | -46.7% | 0.03% | -50.8% |
| Q3 2021 | $9,705,814,000 | +20.0% | 438,780 | -29.7% | 0.06% | +16.7% |
| Q2 2021 | $8,087,040,000 | +50.1% | 624,000 | +50.4% | 0.05% | +38.5% |
| Q1 2021 | $5,387,879,000 | +291.3% | 414,931 | +316.8% | 0.04% | +225.0% |
| Q4 2020 | $1,376,818,000 | – | 99,553 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |